|
SETDB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.110000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.172400E-01 |
| Normal-vs-Stage2 |
4.018600E-01 |
| Normal-vs-Stage3 |
1.559010E-01 |
| Normal-vs-Stage4 |
5.174600E-01 |
| Stage1-vs-Stage2 |
7.086600E-01 |
| Stage1-vs-Stage3 |
2.926600E-01 |
| Stage1-vs-Stage4 |
7.633600E-01 |
| Stage2-vs-Stage3 |
5.757200E-01 |
| Stage2-vs-Stage4 |
9.832600E-01 |
| Stage3-vs-Stage4 |
6.780200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.509600E-02 |
| Normal-vs-AfricanAmerican |
2.910600E-01 |
| Normal-vs-Asian |
7.575200E-01 |
| Caucasian-vs-AfricanAmerican |
6.249000E-01 |
| Caucasian-vs-Asian |
7.221000E-01 |
| AfricanAmerican-vs-Asian |
8.349000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.525020E-01 |
| Normal-vs-Female |
1.494040E-02 |
| Male-vs-Female |
8.748400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.078500E-02 |
| Normal-vs-Extreme_Weight |
9.768600E-01 |
| Normal-vs-Obese |
6.780300E-02 |
| Normal-vs-Extreme_Obese |
5.721200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.700400E-02 |
| Normal_Weight-vs-Obese |
8.279000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.157200E-01 |
| Extreme_Weight-vs-Obese |
7.942300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.182200E-01 |
| Obese-vs-Extreme_Obese |
2.201600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.234420E-02 |
| Normal-vs-Age(41-60Yrs) |
5.138600E-03 |
| Normal-vs-Age(61-80Yrs) |
5.073400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.138000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.747200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.580200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.835770E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.177700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.541600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.968000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.191700E-02 |
| Normal-VS-Type2 PRCC |
5.776000E-01 |
| Normal-VS-KIRP CIMP |
6.511400E-01 |
| Normal-VS-Unclassified PRCC |
8.203600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.690600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.119400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.428800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.469600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.448000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.887570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.183600E-01 |
| Normal-vs-N1 |
3.745700E-02 |
| Normal-vs-N2 |
8.502400E-01 |
| N0-vs-N1 |
6.236200E-02 |
| N0-vs-N2 |
9.922000E-01 |
| N1-vs-N2 |
4.107400E-01 |
|
|
